We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

121 hedge funds and large institutions have $265M invested in Surmodics in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 52 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

23% more capital invested

Capital invested by funds: $215M → $265M (+$49.9M)

3% more funds holding

Funds holding: 118121 (+3)

42% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 52

Holders
121
Holders Change
+3
Holders Change %
+2.54%
% of All Funds
3.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
30
Reduced
52
Closed
7
Calls
Puts
Net Calls
Net Calls Change

SRDX Hedge Fund Activity: Q2 2016 in Review

121 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2016, worth a combined $265M — up 23% from $215M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SRDX positions and 7 closed out — a net gain of 4 holders — while 30 added to existing stakes and 52 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $3.81M. The largest seller was Millennium Management, cutting an estimated $4.49M.

  • 121 institutional investors held Surmodics (SRDX) as of Q2 2016, up from 118 in Q1 2016.
  • Funds reported $265M of Surmodics stock for Q2 2016, up 23% quarter-over-quarter.
  • 11 funds opened new Surmodics positions in Q2 2016 and 7 closed out, a net change of +4 holders.
  • The largest Surmodics buyer in Q2 2016 was Wellington Management Group, an estimated $3.81M added.
  • The largest Surmodics seller in Q2 2016 was Millennium Management, an estimated $4.49M sold.

Based on aggregated 13F filings for Q2 2016.